Copper-67, Global Market Size Forecast, Top 4 Players Rank and Market Share | |
Copper-67 Market Summary Copper-67 (Cu-67) is a short-range, beta-emitting radioisotope which is attractive for medical purposes due to its ability to carry sufficient radiation energy to cause cell death in targeted cells while having a short half-life, limiting unwanted radioactivity in otherwise healthy tissue. Initial data in ongoing clinical trials shows evidence of the therapeutic benefits in children and adults with cancer when compared to conventional cancer therapies. According to the new market research report “Global Copper-67 Market Report 2024-2030”, published by QYResearch, the global Copper-67 market size is projected to reach USD 0.04 billion by 2030, at a CAGR of 7.5% during the forecast period. According to QYResearch Top Players Research Center, the global key manufacturers of Copper-67 include NorthStar Medical Radioisotopes, Iotron Medical, etc. In 2023, the global top three players had a share approximately 71.0% in terms of revenue. NorthStar Medical Radioisotopes is the largest company in the world, accounting for 39.70%, followed by Iotron Medical, accounting for 15.73%. For more information, please contact the following e-mail address: Email: global@qyresearch.com Website: https://www.qyresearch.com | |
Target Prov.: All Provinces Target City : All Cities Last Update : Apr 08, 2024 11:18 PM Number of Views: 54 | Item Owner : Nancy Contact Email: (None) Contact Phone: (None) |
Friendly reminder: Click here to read some tips. |